Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Recommendation of final cum special dividend
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Akums Drugs has recommended a final dividend of Rs. 1.00 per share and a special dividend of Rs. 2.00 per share for FY2026, totaling Rs. 3 per equity share (face value Rs. 2 each). The record date is July 3, 2026. The company reported standalone profit after tax of Rs. 1,116.40 million for FY2026, down from Rs. 1,609.98 million in FY2025 (approximately 31% decline). Despite the profit decline, the board approved these dividends subject to shareholder approval at the 22nd AGM on July 10, 2026. The auditors flagged an ongoing Income Tax Department search and seizure operation from January 2025 and subsequent show cause notices as an emphasis of matter, though no material adjustments were made to the financial results.
The dividend declaration is positive for income-focused investors despite a significant drop in annual profits. The special dividend indicates a one-time cash distribution. The ongoing income tax proceedings remain a risk factor to monitor.